23 articles
BASF CEO Markus Kamieth advocates acquiring rival Evonik Industries following strong third-quarter earnings under his Winning Ways strategy. The deal aims to consolidate BASF's core chemical business
BASF has reportedly raised its acquisition offer for Evonik Industries to €11.2 billion, promising to preserve regional jobs until 2032 and optimize raw material sourcing to improve cost competitivene
BASF CEO Markus Kamieth confirmed readiness to discuss a merger with Evonik Industries, emphasizing value creation without compromising shareholder interests. The proposed combination aims to strength
Evonik Industries partners with Japanese firms to develop a chemical recycling model for polyurethane foam. The project converts discarded foam into high-purity recycled polyols and amines for new pro
Evonik Industries rejected a €10.3 billion acquisition offer from BASF, signaling a major shift in the chemical sector. The report also covers a new amino acids joint venture between CJ CheilJedang an
Evonik Industries rejected BASF's €10.3 billion non-binding takeover offer, stating it was too low for formal talks. Consequently, Evonik's share price surged over 10% while BASF's dipped amidst marke
Evonik Industries rejected a €10.3 billion takeover bid from BASF, deeming the offer too low for negotiations. BASF maintains that exploratory talks remain open despite Evonik confirming no active dis
BASF confirmed exploratory talks with RAG-Stiftung and Evonik Industries regarding a potential takeover of the specialty chemicals firm. The outcome remains open as BASF evaluates strategic acquisitio
BASF is in talks to acquire Evonik Industries, potentially combining Germany’s two largest chemical makers amid high production costs and weak regional demand. Both firms have previously cut costs and
Evonik Industries has commenced construction on an €80 million biotechnology expansion at its Fermas site in Slovakia, targeting completion in early 2028 to boost pharmaceutical intermediate manufactu
Evonik Industries plans to close its Hamburg and Bitterfeld sites in Germany next year, impacting 90 employees due to high operational costs and weak market demand. Production activities will be conso
Evonik Industries AG appointed Claus Rettig as interim CEO while current leader Christian Kullmann recovers from surgery. Rettig joins the executive board effective September 1st and retains responsib
Evonik Industries in Slovakia utilizes engineered microbes to ferment renewable raw materials into products like pharmaceutical ingredients and biopolymers. This investment demonstrates a viable pathw
Evonik Industries AG reported a 31% drop in Q2 net profit due to impairments, yet adjusted EBITDA beat estimates driven by higher volumes and prices. The company upgraded its 2026 outlook citing Middl
Evonik Industries will utilize Celtic Renewables' bio-based butanol, derived from local feedstocks like whiskey pot ale, to produce sustainable cosmetic emollients. This partnership aims to reduce Sco
Evonik Industries AG upgraded its 2026 adjusted EBITDA guidance to €2.0–2.2 billion following strong Q2 performance, exceeding prior forecasts of €1.7–2.0 billion.
Evonik Industries has agreed to sell selected pharmaceutical ingredient production assets at its Hanau site to contract manufacturer ProChem Group. The move aligns with Evonik's strategy to streamline
Evonik Industries announced an extension of its restructuring program, cutting 3,200 additional jobs by 2029 and discontinuing its unprofitable polyester business by 2027. The move aims to improve eff
Evonik Industries is restructuring its R&D department to accelerate innovation in biotech and green energy by aligning researchers directly with business units. Two-thirds of staff will now work close
Evonik Industries AG has partnered with the University of Guanajuato to develop sustainable, lower-toxicity chemical solutions for mining using its biosurfactant platform. The collaboration aims to re
Evonik Industries AG signed an agreement to supply its Sepuran Green membrane technology to Malaysian bioenergy firm MTC Orec Sdn Bhd for biogas upgrading projects across Asia. The proprietary membran
Evonik Industries restructured its R&D division into an "Innovation Factory" to accelerate technology commercialization within five years. Replacing the former Creavis department, the unit aims to int
Evonik Industries maintained its 2026 adjusted EBITDA guidance of €1.7–2.0 billion, noting no expected recovery in global chemical demand despite strong performance in China.
ChemBrief